FGFR1 rearranged hematological neoplasms–molecularly defined and clinically heterogeneous

Mrinal M. Patnaik; Rhett P. Ketterling; Ayalew Tefferi

doi:10.1080/10428194.2018.1429607

FGFR1 rearranged hematological neoplasms–molecularly defined and clinically heterogeneous

Mrinal M. Patnaik, Rhett P. Ketterling, Ayalew Tefferi

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	1520-1522
Number of pages	3
Journal	Leukemia and Lymphoma
Volume	59
Issue number	7
DOIs	https://doi.org/10.1080/10428194.2018.1429607
State	Published - Jul 3 2018

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1080/10428194.2018.1429607

Cite this

@article{ce16644c6e5944819572314504d3f8f0,

title = "FGFR1 rearranged hematological neoplasms–molecularly defined and clinically heterogeneous",

author = "Patnaik, {Mrinal M.} and Ketterling, {Rhett P.} and Ayalew Tefferi",

note = "Funding Information: Current publication is supported in part by grants from the {\textquoteleft}The Gerstner Family Career Development Award{\textquoteright} and the Mayo Clinic Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA. Funding Information: This publication was supported by CTSA Grant Number KL2 TR000136 from the National Center for Advancing Translational Science (NCATS).",

year = "2018",

month = jul,

day = "3",

doi = "10.1080/10428194.2018.1429607",

language = "English (US)",

volume = "59",

pages = "1520--1522",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "7",

}

TY - JOUR

T1 - FGFR1 rearranged hematological neoplasms–molecularly defined and clinically heterogeneous

AU - Patnaik, Mrinal M.

AU - Ketterling, Rhett P.

AU - Tefferi, Ayalew

N1 - Funding Information: Current publication is supported in part by grants from the ‘The Gerstner Family Career Development Award’ and the Mayo Clinic Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA. Funding Information: This publication was supported by CTSA Grant Number KL2 TR000136 from the National Center for Advancing Translational Science (NCATS).

PY - 2018/7/3

Y1 - 2018/7/3

UR - http://www.scopus.com/inward/record.url?scp=85041319937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041319937&partnerID=8YFLogxK

U2 - 10.1080/10428194.2018.1429607

DO - 10.1080/10428194.2018.1429607

M3 - Comment/debate

C2 - 29384399

AN - SCOPUS:85041319937

SN - 1042-8194

VL - 59

SP - 1520

EP - 1522

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 7

ER -

FGFR1 rearranged hematological neoplasms–molecularly defined and clinically heterogeneous

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this